BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6635288)

  • 21. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM; Olesin AI
    Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Termination of paroxysmal supraventricular tachycardia with oral diltiazem.
    Pauszek ME
    Indiana Med; 1991 May; 84(5):318-20. PubMed ID: 2061599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery.
    Amar D; Roistacher N; Rusch VW; Leung DH; Ginsburg I; Zhang H; Bains MS; Downey RJ; Korst RJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):790-8. PubMed ID: 11003764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
    Vietti-Ramus G; Veglio F; Marchisio U; Burzio P; Latini R
    Int J Cardiol; 1992 Apr; 35(1):77-85. PubMed ID: 1563883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
    Ricevuti A; Bianchi C; Bonifazi C; Coppetti S; Ferrari O; Rinaldo R; Rizzi M; Tavecchi L; Zampaglione G; Ziletti G; Distante S
    G Ital Cardiol; 1981; 11(6):812-9. PubMed ID: 7319187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study.
    Rehnqvist N
    Ann Clin Res; 1981; 13 Suppl 30():68-72. PubMed ID: 7027895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium antagonists in patients with cardiovascular disease. Current perspectives.
    Winniford MD; Hillis LD
    Medicine (Baltimore); 1985 Jan; 64(1):61-73. PubMed ID: 3880854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experience with the preparation 39089-Ba in some arrhythmias].
    Sodi Pallares D
    Arch Inst Cardiol Mex; 1968; 38(5):707-13. PubMed ID: 4178512
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N; Penev A; Kaponov Kh
    Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving Appropriate Dosing of Intravenous dilTIAZem in Patients With Atrial Fibrillation or Flutter With Rapid Ventricular Response in the Emergency Department.
    Pon G; Pelsue B; Gulbis B
    J Emerg Nurs; 2020 Mar; 46(2):246-253. PubMed ID: 31839326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment results with N-(n-propyl)-ajmaline hydrogen tartrate].
    Kottysch R
    Med Klin; 1969 Jan; 64(4):156-60. PubMed ID: 4181967
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter.
    Dias VC; Weir SJ; Ellenbogen KA
    Circulation; 1992 Nov; 86(5):1421-8. PubMed ID: 1423955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paroxysmal atrial fibrillation and flutter and "occult" arterial hypertension. The importance of the ambulatory monitoring of the blood pressure. Apropos 2 cases].
    Carmona J; Amado P; Castanheira J; Nazaré J; Araújo V
    Rev Port Cardiol; 1993 Oct; 12(10):865-70, 806. PubMed ID: 8286135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of flecainide acetate in the treatment of supraventricular tachyarrhythmias.
    Marwick TH; Woodhouse SP
    Am J Cardiol; 1988 Jul; 62(1):171. PubMed ID: 3132846
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous diltiazem hydrochloride rather than verapamil for resistant paroxysmal supraventricular tachycardia.
    Peitz TJ
    West J Med; 1993 Nov; 159(5):598-9. PubMed ID: 8279162
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.
    Ellenbogen KA; Dias VC; Cardello FP; Strauss WE; Simonton CA; Pollak SJ; Wood MA; Stambler BS
    Am J Cardiol; 1995 Jan; 75(1):45-9. PubMed ID: 7801862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation.
    Chiladakis JA; Stathopoulos C; Davlouros P; Manolis AS
    Int J Cardiol; 2001 Jul; 79(2-3):287-91. PubMed ID: 11461753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study.
    Ellenbogen KA; Dias VC; Plumb VJ; Heywood JT; Mirvis DM
    J Am Coll Cardiol; 1991 Oct; 18(4):891-7. PubMed ID: 1894861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy and method of intravenous administration of isoptin in paroxysmal supraventricular tachyarrhythmias].
    Anshelevich IuV; Sorokina TA; Kalvelis AD; Braun VB; Dumesh SZ
    Ter Arkh; 1983; 55(5):89-92. PubMed ID: 6612607
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preventive use of diltiazem to suppress supraventricular tachyarrhythmia in the patients after esophagectomy].
    Shimada M; Namai H; Morisaki H; Ochiai R; Takeda J; Fukushima K
    Masui; 1997 May; 46(5):658-63. PubMed ID: 9185464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.